Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Target |
Action antagonists |
Mechanism LPAR1 antagonists(Lysophosphatidic acid receptor Edg-2 antagonists), Lysophosphatidic acid receptors antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hydrocephalus | Discovery | - | 22 Jun 2023 | |
| Neoplasms | Discovery | - | 22 Jun 2023 | |
| Other Diseases | Discovery | - | 22 Jun 2023 | |
| Renal fibrosis | Discovery | - | 22 Jun 2023 | |
| Respiratory Diseases | Discovery | - | 22 Jun 2023 | |
| Rheumatoid Arthritis | Discovery | - | 22 Jun 2023 |





